Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-33,530 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-17,173 Reduced 33.87%
33,530 $165,000
Q2 2021

Aug 16, 2021

SELL
N/A
-249,543 Reduced 83.11%
50,703 $268,000
Q1 2021

May 17, 2021

BUY
N/A
78,456 Added 35.37%
300,246 $1.44 Million
Q4 2020

Feb 16, 2021

BUY
N/A
45,800 Added 26.02%
221,790 $960,000
Q3 2020

Nov 16, 2020

BUY
N/A
49,287 Added 38.9%
175,990 $725,000
Q2 2020

Aug 17, 2020

SELL
N/A
-37,653 Reduced 22.91%
126,703 $324,000
Q1 2020

May 15, 2020

BUY
N/A
14,377 Added 9.59%
164,356 $475,000
Q4 2019

Feb 14, 2020

BUY
N/A
71,379 Added 90.81%
149,979 $568,000
Q3 2019

Nov 14, 2019

BUY
N/A
78,600 New
78,600 $402,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.